Endurance Wealth Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$3K Hold
70
﹤0.01% 589
2023
Q1
$2K Hold
70
﹤0.01% 616
2022
Q4
$3K Hold
70
﹤0.01% 581
2022
Q3
$3K Hold
70
﹤0.01% 549
2022
Q2
$5K Sell
70
-120
-63% -$8.77K ﹤0.01% 536
2022
Q1
$15K Hold
190
﹤0.01% 487
2021
Q4
$20K Hold
190
﹤0.01% 444
2021
Q3
$17K Hold
190
﹤0.01% 483
2021
Q2
$17K Buy
+190
New +$16.1K ﹤0.01% 476

Other funds holding SYNH

Endurance Wealth Management's SYNH Position: Q2 2023 in Review

Endurance Wealth Management held its Syneos Health, Inc. Class A Common Stock (SYNH) position steady in Q2 2023 at 70 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #589.

Endurance Wealth Management first reported a position in SYNH in Q2 2021 and has held it in 9 quarters since. The position peaked at $20K in Q4 2021. 316 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Endurance Wealth Management held 70 shares of Syneos Health, Inc. Class A Common Stock worth $3K as of Q2 2023.
  • Endurance Wealth Management left its Syneos Health, Inc. Class A Common Stock share count unchanged in Q2 2023.
  • Syneos Health, Inc. Class A Common Stock made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #589 holding.
  • Endurance Wealth Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and has held it in 9 quarters since.
  • Endurance Wealth Management's Syneos Health, Inc. Class A Common Stock position peaked at $20K in Q4 2021.
  • 316 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.